SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review is a paper indexed in ScholarIQ from OpenAlex.
How many citations does SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review have?
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review has 986 citations in the OpenAlex counts ScholarIQ stores.
When was SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review published?
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review has 2018 year in the ScholarIQ index.
What is the open-access status of SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review?
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review has bronze oa status in the ScholarIQ index.
What is the DOI of SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review?
The DOI for SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review is on the source record.
What is the PMID of SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review?
The PMID for SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review is on the source record.
What is the OpenAlex record for SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review?
The OpenAlex for SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review is on the source record.